
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [ADAP] Adaptimmune Therapeutics plc
Data updated 2025-Apr-25 (Friday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab
Share
2025-Apr-25 Friday
Open | $0.28 | High | $0.28 0.00% |
---|---|---|---|
Close | $0.27 | Low | $0.26 -8.17% |
Volume | 469 Thousand 0.66x | Volatility | 8.90% |
Change |
$0.00
-0.49%
|
Streak | ↓ 1 days -0.49% |
20d SMA | $0.25 +7.2% | 50d SMA | $0.38 -29.6% | 100d SMA | $0.49 -46.2% | 200d SMA | $0.74 -64.2% |
RSI | 45 | MACD | 0.01 | ADX | 25.0 | Stochastic Oscillator | 52.6 47.7 |
CCI | 66.4 | ATR | 0.03 | OBV | 123 Million | Chaikin A/D | -126 Million |
Market Cap | 341 M | PEG Ratio | Trailing P/E | Forward P/E | |||
Price/Sales (ttm) | 4.6 | Price/Book (mrq) | 8.62 | EV/Revenue (ttm) | 3.63 | EV/EBITDA (ttm) | -1.71 |
% Held by Insiders | 0.21% | % Held by Institutions | 70.02% | Shares Short | 3.11 M | Shares Short (prior month) | 2.93 M |
Short Ratio | 1.55 | Short % of Outstanding | 1.26% | Short % of Float | 0.47% | Shares Short Change (mom) | +6.1% |
Revenue/Share (ttm) | $0.30 | Profit Margin (ttm) | -188.90% | Operating Margin (ttm) | EBITDA (ttm) | -128 M | |
Diluted EPS (ttm) | $-0.54 | Current Ratio (mrq) | 2.85 | Return on Assets (ttm) | -28.22% | Return on Equity (ttm) | -187.61% |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | -97.90% | Operating Cash Flow (ttm) | -141 M | Free Cash Flow (ttm) | -73.8 M | |
Choose view type
Monthly Performance for Adaptimmune Therapeutics plc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Adaptimmune Therapeutics plc up to close of 2025-Apr-25 at $0.27
Period | Frequency | Performance | % off High | % off Low | Volatility | % off SMA | % off EMA | Relative Volume |
---|---|---|---|---|---|---|---|---|
01 Trailing 5-days
|
|
+11.38%
|
-10.9%
|
+10.8%
|
25.0%
|
+2.3%
|
+2.3%
|
0.66x
|
02 Trailing 10-days
|
|
+23.40%
|
-10.9%
|
+30.4%
|
50.0%
|
+6.9%
|
+4.2%
|
0.49x
|
03 Trailing 20-days
|
|
+20.59%
|
-19.6%
|
+36.0%
|
65.0%
|
+7.2%
|
-1.2%
|
1.01x
|
04 Trailing 30-days
|
|
-40.79%
|
-44.0%
|
+36.0%
|
135.0%
|
-4.2%
|
-10.6%
|
1.25x
|
05 Trailing 50-days
|
|
-54.17%
|
-57.2%
|
+36.0%
|
210.0%
|
-29.6%
|
-25.4%
|
1.05x
|
06 Trailing 100-days
|
|
-63.41%
|
-64.1%
|
+36.0%
|
270.0%
|
-46.2%
|
-44.7%
|
1.03x
|
07 Trailing 200-days
|
|
-77.89%
|
-82.1%
|
+36.0%
|
640.0%
|
-64.2%
|
-59.1%
|
1.02x
|
08 Month-to-date
|
|
+34.67%
|
-19.6%
|
+36.0%
|
65.0%
|
|
|
|
09 Quarter-to-date
|
|
+34.67%
|
-19.6%
|
+36.0%
|
65.0%
|
|
|
|
10 Year-to-date
|
|
-50.75%
|
-61.3%
|
+36.0%
|
245.0%
|
|
|
|
11 Trailing 52-weeks
|
|
-74.97%
|
-82.1%
|
+36.0%
|
640.0%
|
|
|
|
3-month Performance Benchmarks for Adaptimmune Therapeutics plc:
Related to Adaptimmune Therapeutics plc
Information for Adaptimmune Therapeutics plc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Apr-25 on Google
SEC Reports : Quarterly reports around 2025-Apr-25 on SEC Edgar
Compare Adaptimmune Therapeutics plc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Adaptimmune Therapeutics plc
Industry : Biotechnology industry performance which includes Adaptimmune Therapeutics plc